Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27


Multifunctional lipid-coated calcium phosphate nanoplatforms for complete inhibition of large triple negative breast cancer via targeted combined therapy.

Tang J, Li B, Howard CB, Mahler SM, Thurecht KJ, Wu Y, Huang L, Xu ZP.

Biomaterials. 2019 Sep;216:119232. doi: 10.1016/j.biomaterials.2019.119232. Epub 2019 May 31.


Modulating Targeting of Poly(ethylene glycol) Particles to Tumor Cells Using Bispecific Antibodies.

Cui J, Ju Y, Houston ZH, Glass JJ, Fletcher NL, Alcantara S, Dai Q, Howard CB, Mahler SM, Wheatley AK, De Rose R, Brannon PT, Paterson BM, Donnelly PS, Thurecht KJ, Caruso F, Kent SJ.

Adv Healthc Mater. 2019 May;8(9):e1801607. doi: 10.1002/adhm.201801607. Epub 2019 Mar 14.


Selection of Antibodies to Transiently Expressed Membrane Proteins Using Phage Display.

Jones ML, Mahler SM, Kumble S.

Methods Mol Biol. 2018;1827:179-195. doi: 10.1007/978-1-4939-8648-4_10.


Enhanced delivery of siRNA to triple negative breast cancer cells in vitro and in vivo through functionalizing lipid-coated calcium phosphate nanoparticles with dual target ligands.

Tang J, Howard CB, Mahler SM, Thurecht KJ, Huang L, Xu ZP.

Nanoscale. 2018 Mar 1;10(9):4258-4266. doi: 10.1039/c7nr08644j.


Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models.

Alfaleh MA, Howard CB, Sedliarou I, Jones ML, Gudhka R, Vanegas N, Weiss J, Suurbach JH, de Bakker CJ, Milne MR, Rumballe BA, MacDiarmid JA, Brahmbhatt H, Mahler SM.

PLoS One. 2017 Oct 23;12(10):e0186137. doi: 10.1371/journal.pone.0186137. eCollection 2017.


Insights into the interfacial structure-function of poly(ethylene glycol)-decorated peptide-stabilised nanoscale emulsions.

Tayeb HH, Piantavigna S, Howard CB, Nouwens A, Mahler SM, Middelberg APJ, He L, Holt SA, Sainsbury F.

Soft Matter. 2017 Nov 8;13(43):7953-7961. doi: 10.1039/c7sm01614j.


Recent Advances in the Generation of Antibody-Nanomaterial Conjugates.

Sivaram AJ, Wardiana A, Howard CB, Mahler SM, Thurecht KJ.

Adv Healthc Mater. 2018 Jan;7(1). doi: 10.1002/adhm.201700607. Epub 2017 Sep 29. Review.


Isolation of serotype-specific antibodies against dengue virus non-structural protein 1 using phage display and application in a multiplexed serotyping assay.

Lebani K, Jones ML, Watterson D, Ranzoni A, Traves RJ, Young PR, Mahler SM.

PLoS One. 2017 Jul 6;12(7):e0180669. doi: 10.1371/journal.pone.0180669. eCollection 2017.


Computational Identification of Antibody Epitopes on the Dengue Virus NS1 Protein.

Jones ML, Legge FS, Lebani K, Mahler SM, Young PR, Watterson D, Treutlein HR, Zeng J.

Molecules. 2017 Apr 10;22(4). pii: E607. doi: 10.3390/molecules22040607.


Biosimilars approved for treatment of inflammatory rheumatological diseases.

Mahler SM, Wardiana A, Jones ML, de Bakker CJ, Graham GG, Howard CB.

Int J Rheum Dis. 2016 Nov;19(11):1043-1048. doi: 10.1111/1756-185X.13037. No abstract available.


Beyond Antibodies: Development of a Novel Protein Scaffold Based on Human Chaperonin 10.

Alsultan AM, Chin DY, Howard CB, de Bakker CJ, Jones ML, Mahler SM.

Sci Rep. 2016 Nov 22;5:37348. doi: 10.1038/srep37348.


Nanoyeast and Other Cell Envelope Compositions for Protein Studies and Biosensor Applications.

Grewal YS, Shiddiky MJ, Mahler SM, Cangelosi GA, Trau M.

ACS Appl Mater Interfaces. 2016 Nov 16;8(45):30649-30664. Epub 2016 Nov 4. Review.


CMRF-56(+) blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responses.

Fromm PD, Papadimitrious MS, Hsu JL, Van Kooten Losio N, Verma ND, Lo TH, Silveira PA, Bryant CE, Turtle CJ, Prue RL, Vukovic P, Munster DJ, Nagasaki T, Barnard RT, Mahler SM, Anguille SA, Berneman Z, Horvath LG, Bradstock KF, Joshua DE, Clark GJ, Hart DN.

Oncoimmunology. 2016 May 5;5(6):e1168555. doi: 10.1080/2162402X.2016.1168555. eCollection 2016 Jun.


Overcoming Instability of Antibody-Nanomaterial Conjugates: Next Generation Targeted Nanomedicines Using Bispecific Antibodies.

Howard CB, Fletcher N, Houston ZH, Fuchs AV, Boase NR, Simpson JD, Raftery LJ, Ruder T, Jones ML, de Bakker CJ, Mahler SM, Thurecht KJ.

Adv Healthc Mater. 2016 Aug;5(16):2055-68. doi: 10.1002/adhm.201600263. Epub 2016 Jun 10.


Preparation of optimized lipid-coated calcium phosphate nanoparticles for enhanced in vitro gene delivery to breast cancer cells.

Tang J, Li L, Howard CB, Mahler SM, Huang L, Xu ZP.

J Mater Chem B. 2015 Sep 7;3(33):6805-6812. Epub 2015 Jul 29.


Targeting membrane proteins for antibody discovery using phage display.

Jones ML, Alfaleh MA, Kumble S, Zhang S, Osborne GW, Yeh M, Arora N, Hou JJ, Howard CB, Chin DY, Mahler SM.

Sci Rep. 2016 May 18;6:26240. doi: 10.1038/srep26240.


Biosensing made easy with PEG-targeted bi-specific antibodies.

Raftery LJ, Grewal YS, Howard CB, Jones ML, Shiddiky MJ, Carrascosa LG, Thurecht KJ, Mahler SM, Trau M.

Chem Commun (Camb). 2016 Apr 28;52(33):5730-3. doi: 10.1039/c6cc01916a.


Effect of energy source, salt concentration and loading force on colloidal interactions between Acidithiobacillus ferrooxidans cells and mineral surfaces.

Diao M, Nguyen TA, Taran E, Mahler SM, Nguyen AV.

Colloids Surf B Biointerfaces. 2015 Aug 1;132:271-80. doi: 10.1016/j.colsurfb.2015.05.026. Epub 2015 May 22.


Nanocell targeting using engineered bispecific antibodies.

Taylor K, Howard CB, Jones ML, Sedliarou I, MacDiarmid J, Brahmbhatt H, Munro TP, Mahler SM.

MAbs. 2015;7(1):53-65. doi: 10.4161/19420862.2014.985952.


Comparison and evaluation of immobilization methods for preparing bacterial probes using acidophilic bioleaching bacteria Acidithiobacillus thiooxidans for AFM studies.

Diao M, Taran E, Mahler SM, Nguyen AV.

J Microbiol Methods. 2014 Jul;102:12-4. doi: 10.1016/j.mimet.2014.04.004. Epub 2014 Apr 24.


Supplemental Content

Loading ...
Support Center